Glycomics study and glycoprotein glycoconjugate mapping based on refractory epilepsy in children

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400089875

Enrollment

Unknown

Registered

2024-09-18

Start date

2024-10-01

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intractable epilepsy

Interventions

Childhood Refractory Epilepsy Group:Collection of cerebrospinal fluid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (i) Clinical diagnosis meets the criteria for confirmation of refractory epilepsy (ILAE, 2010); (ii) Gender and age are not limited; (iii) Informed consent and willingness to follow up.

Exclusion criteria

Exclusion criteria: (i) patients with incomplete information on key diseases; (ii) cases who did not want to participate in the study or could not be followed up; and (iii) lost cases.

Design outcomes

Primary

Measure	Time frame
Glycomics study;Novel glycoprotein glycochain molecules associated with pathology of refractory epilepsy;	—

Countries

China

Contacts

Public ContactHu Chunhui

Fujian Children's Hospital

huchunhui1989@126.com+86 177 2078 1780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026